Study Stopped
Sponsor decision due to the low recruitment rate
Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer
IMPULSO
1 other identifier
observational
344
1 country
18
Brief Summary
The purpose of this study is to evaluate of gender differences on the psychosocial and economic impact in patients with advanced non-small cell lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2015
Typical duration for all trials
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2014
CompletedFirst Posted
Study publicly available on registry
January 12, 2015
CompletedStudy Start
First participant enrolled
February 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2017
CompletedDecember 15, 2017
December 1, 2017
2.8 years
December 3, 2014
December 14, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Psychosocial impact (Test Family APGAR, Partner Test and adapted Duke-UNC-11 Scale)
The procedures for assessing psychosocial impact are: Test Family APGAR, Partner Test and adapted Duke-UNC-11 Scale. These tests will be performed by the investigator at visit baseline, visit 2 visit 3 and visit 4, according to the site's standard practice until patient death or for up to 24 months from the time of inclusion.
2 years
Economic impact (employment status, working hours, income range, public assistance, family support ...)
The procedures for assessing economic impact are some specific economic variables (employment status, working hours, income range, public assistance, family support ...)
2 years
Secondary Outcomes (2)
Influence of treatment (reatment received, treatment received, tumour ssessment, Medical history, including history of smoking, ECOG performance status, associated medical conditions and prior treatments administered (surgery, adjuvant treatment).
2 years
Psychosocial and economic impact on the primary caregiver (Zarit Caregiver Burden Questionnaire and Test assessing the economic impact)
2 years
Study Arms (2)
male
It will be stratified based on biological sex, age and smoking to guarantee homogeneity between the cohorts.
female
It will be stratified based on biological sex, age and smoking to guarantee homogeneity between the cohorts.
Interventions
Eligibility Criteria
Approximately 1250 patients over 18 years of age (approximately 50% men/women), with metastatic NSCLC, who are going to commence first-line treatment and who have a life expectancy of over three months will be included. They will be distributed into two cohorts (men and women) at 50% and will be distributed by age group and smoking status to facilitate the homogeneity between the two cohorts.
You may qualify if:
- Patients diagnosed with stage IV NSCLC who are going to commence first line treatment
- Patients over the age of 18
- ECOG 0-3
- Patients who have granted their informed consent, preferably in writing, but otherwise, verbal with witnesses who are independent of the research team
- Life expectancy of over three months
- Speak fluent Spanish, in order to be able to complete the study questionnaires
- Patients able to read and write with no problems
You may not qualify if:
- Previous systemic treatment for metastatic NSCLC. The administration of neoadjuvant or adjuvant radiotherapy and/or chemotherapy is permitted provided it was completed major or equal 6 months prior
- Dementia or a significantly altered mental state that could affect comprehension or the ability to grant informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
Hospital Universitario Son Espases
Palma de Mallorca, Balearic Islands, 07010, Spain
Hospital de Son Llàtzer
Palma de Mallorca, Balearic Islands, 07198, Spain
Hospital German Trias i Pujol
Badalona, Barcelona, 08916, Spain
Hospital Provincial de Castellón
Castellon, Castellón, 12006, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
Complexo Hospitalario Universitario A Coruña
A Coruña, 15006, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, 08026, Spain
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
Fundación Jiménez Díaz
Madrid, 28040, Spain
Hospital Clínico Universitario San Carlos
Madrid, 28040, Spain
Hospital Universitario La Paz
Madrid, 28046, Spain
Hospital General Universitario de Valencia
Valencia, 46014, Spain
Hospital Arnau de Villanova
Valencia, 46015, Spain
Hospital La Fe
Valencia, 46026, Spain
Hospital Clínico Universitario Lozano Blesa
Zaragoza, 50009, Spain
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
Related Publications (1)
Vinolas NN, Garcia-Campelo R, Majem M, Carcereny E, Isla D, Gonzalez-Larriba JL, Coves J, De-Castro J, Domine M, Lianes P, Artal A, Remon J, Felip E, Garrido P. Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study. BMC Psychol. 2020 Nov 23;8(1):123. doi: 10.1186/s40359-020-00489-z.
PMID: 33228796DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
María Rosario García, MD
Complejo Hospitalario A Coruña
- STUDY CHAIR
Pilar Garrido, MD
Hospital Universitario Ramón y Cajal
- STUDY CHAIR
Nuria Viñolas, MD
Hospital Clinic of Barcelona
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2014
First Posted
January 12, 2015
Study Start
February 3, 2015
Primary Completion
November 30, 2017
Study Completion
November 30, 2017
Last Updated
December 15, 2017
Record last verified: 2017-12